Sequential chemotherapy and radiotherapy as sandwich therapy for the treatment of high risk endometrial cancer

Abstract

The preliminary results from our study suggest that the sandwich approach to treating high risk endometrial cancer patients is feasible. Hematologic toxicity was well tolerated and non-hematologic toxicity was mild and easily managed. Further study of this novel regimen in a larger patient population with extended follow-up is necessary.